Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,871 | 71,734 | 140,231 | 137,160 | 129,038 |
| Receivables | 126,785 | 110,414 | 120,741 | 118,262 | 112,521 |
| Inventories | 233,043 | 189,133 | 230,455 | 223,632 | 215,232 |
| Income taxes - deferred | 58,293 | 30,564 | 44,276 | 48,349 | 48,459 |
| Other current assets | 0 | 99,785 | 0 | 0 | 0 |
| TOTAL | $521,950 | $529,321 | $562,589 | $564,161 | $539,746 |
| Non-Current Assets | |||||
| PPE Net | 210,111 | 193,626 | 203,882 | 206,668 | 205,667 |
| Intangibles | 801,626 | 776,047 | 763,480 | 776,986 | 797,095 |
| Other Non-Current Assets | 17,120 | 88,425 | 15,783 | 15,208 | 13,415 |
| TOTAL | $1,028,857 | $1,058,098 | $983,145 | $998,862 | $1,016,177 |
| Total Assets | $1,550,807 | $1,587,419 | $1,545,734 | $1,563,023 | $1,555,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 42,630 | 28,867 | 45,935 | 47,004 | 46,428 |
| Accrued Expenses | 74,247 | 74,452 | 77,130 | 75,487 | 66,183 |
| TOTAL | $126,805 | $126,025 | $130,123 | $126,902 | $116,831 |
| Non-Current Liabilities | |||||
| Long Term Debt | 396,250 | 413,125 | 410,000 | 421,875 | 421,875 |
| Deferred Revenues | 4,303 | 5,176 | 5,183 | 4,411 | 4,220 |
| Other Non-Current Liabilities | 247,222 | 243,530 | 242,851 | 243,476 | 243,405 |
| TOTAL | $735,903 | $757,072 | $729,633 | $746,891 | $759,892 |
| Total Liabilities | $862,708 | $883,097 | $859,756 | $873,793 | $876,723 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,869 | 65,557 | 65,576 | 65,197 | 65,134 |
| Common Shares | 418 | 416 | 415 | 415 | 415 |
| Retained earnings | 323,344 | 314,960 | 297,794 | 287,987 | 283,162 |
| Other shareholders' equity | -47,737 | -23,609 | -14,439 | 1,732 | 1,806 |
| TOTAL | $688,099 | $704,322 | $685,978 | $689,230 | $679,200 |
| Total Liabilities And Equity | $1,550,807 | $1,587,419 | $1,545,734 | $1,563,023 | $1,555,923 |